China NT Pharma Group Company Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 111.233 million compared to CNY 89.436 million a year ago. Operating income was CNY 28.310 million compared to operating loss of CNY 21.452 million a year ago. Net loss was CNY 2.654 million compared to CNY 83.207 million a year ago. Basic loss per share was CNY 0.0014 compared to CNY 0.0437 a year ago. Basic loss per share from continuing operations was CNY 0.0014 compared to CNY 0.0245 a year ago.